BISGIN, A. Et Al. 2008. Clinical significance of TRAIL and its receptor expression profiles on CD4+CD25+Foxp3+Tregs and CD8+CD25+T cells in patients with rheumatoid arthritis. 16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy , (Brugge, Belgium), 1148-1149.

BISGIN, A., YAZISIZ, V., ULKER, M., Terzioglu, E., & ŞANLIOĞLU, S., (2008). Clinical significance of TRAIL and its receptor expression profiles on CD4+CD25+Foxp3+Tregs and CD8+CD25+T cells in patients with rheumatoid arthritis . 16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy (pp.1148-1149). Brugge, Belgium

BISGIN, Atil Et Al. "Clinical significance of TRAIL and its receptor expression profiles on CD4+CD25+Foxp3+Tregs and CD8+CD25+T cells in patients with rheumatoid arthritis," 16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Brugge, Belgium, 2008

BISGIN, Atil Et Al. "Clinical significance of TRAIL and its receptor expression profiles on CD4+CD25+Foxp3+Tregs and CD8+CD25+T cells in patients with rheumatoid arthritis." 16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy , Brugge, Belgium, pp.1148-1149, 2008

BISGIN, A. Et Al. (2008) . "Clinical significance of TRAIL and its receptor expression profiles on CD4+CD25+Foxp3+Tregs and CD8+CD25+T cells in patients with rheumatoid arthritis." 16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy , Brugge, Belgium, pp.1148-1149.

@conferencepaper{conferencepaper, author={Atil BISGIN Et Al. }, title={Clinical significance of TRAIL and its receptor expression profiles on CD4+CD25+Foxp3+Tregs and CD8+CD25+T cells in patients with rheumatoid arthritis}, congress name={16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy}, city={Brugge}, country={Belgium}, year={2008}, pages={1148-1149} }